Isabel Aznarez
Impact in
- Genetics top 10%
- Genetics and Neurodevelopmental Disorders
- Neurogenetic and Muscular Disorders Research
- Psychiatry and Mental health top 10%
- Epilepsy research and treatment
Papers in
-
- RNA and protein synthesis mechanisms 4
- RNA Research and Splicing 4
- RNA modifications and cancer 3
- Advanced biosensing and bioanalysis techniques 1
-
- Cystic Fibrosis Research Advances 6
- Tracheal and airway disorders 2
- Co-authors
- Juergen Scharner (2 shared papers)Gene Liau (3 shared papers)Tomoki Nomakuchi (2 shared papers)Adrian R. Krainer (2 shared papers)Han Zhou (2 shared papers)Frank Rigo (1 shared paper)Lori L. Isom (1 shared paper)Meena Meena (1 shared paper)
- Journals
- Molecular Therapy (1 paper)Science Translational Medicine (1 paper)Human Molecular Genetics (1 paper)Nature Communications (1 paper)Cell Reports (1 paper)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Isabel Aznarez
13 papers receiving 721 citations
Hit Papers
Peers
Comparison fields: 5 of 60
- Genetics 102
- Psychiatry and Mental health 130
- Molecular Biology 511
- Genetics 169
- Cellular and Molecular Neuroscience 97
Countries citing papers authored by Isabel Aznarez
This map shows the geographic impact of Isabel Aznarez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Aznarez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Aznarez more than expected).
Fields of papers citing papers by Isabel Aznarez
This network shows the impact of papers produced by Isabel Aznarez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Aznarez. The network helps show where Isabel Aznarez may publish in the future.
Co-authors
The 25 scholars most cited alongside Isabel Aznarez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Antisense oligonucleotides increase Scn1a expression and reduce seizures and SUDEP incidence in a mouse model of Dravet syndrome Hit paper breakdown → | 2020 | 213 |
| 2 | 2020 | 138 | |
| 3 | 2008 | 86 | |
| 4 | 2015 | 78 | |
| 5 | 2020 | 69 | |
| 6 | 2018 | 55 | |
| 7 | 2003 | 48 | |
| 8 | 2003 | 22 | |
| 9 | 2002 | 16 | |
| 10 | [Analysis of mutations in the CFTR gene in patients diagnosed with cystic fibrosis in Poland]. | 2000 | 6 |
| 11 | Antisense oligonucleotide mediated increase of OPA1 expression using TANGO technology for the treatment of autosomal dominant optic atrophy | 2020 | 3 |
| 12 | 2004 | 1 | |
| 13 | 2002 | 1 |
About Isabel Aznarez
Isabel Aznarez is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Genetics, Surgery and Cellular and Molecular Neuroscience, having authored 13 papers that have together received 736 indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (6 papers), RNA and protein synthesis mechanisms (4 papers), RNA Research and Splicing (4 papers), RNA modifications and cancer (3 papers), Neurogenetic and Muscular Disorders Research (2 papers), Tracheal and airway disorders (2 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper) and Advanced biosensing and bioanalysis techniques (1 paper). The work is most often cited by research in Genetics (102 citations), Psychiatry and Mental health (130 citations), Molecular Biology (511 citations), Genetics (169 citations) and Cellular and Molecular Neuroscience (97 citations). Isabel Aznarez has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Juergen Scharner, Gene Liau, Tomoki Nomakuchi, Adrian R. Krainer, Han Zhou, Frank Rigo, Lori L. Isom, Meena Meena, Anne Christiansen and Qian Lin. Their work appears in journals such as Molecular Therapy, Science Translational Medicine, Human Molecular Genetics, Nature Communications and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.